RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
NCT06273748 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 290
Last updated 2026-03-27
Summary
Uveitis is an inflammatory disease of the uvea, one of the highly vascularized fundamental structures of the eye. It is a rare condition in children, with an incidence in the pediatric population ranging from 2% to 14% of all uveitis cases. The diagnosis and management of patients with uveitis rely on a multidisciplinary approach involving an ophthalmologist, a rheumatologist, and an infectious disease specialist to establish the correct diagnosis and assess the involvement of other organs. In Italy, there is no national or regional registry for non-infectious chronic uveitis as per the Prime Ministerial Decree (DPCM) of March 3, 2017 (Identification of surveillance systems and registries for mortality, tumors, and other diseases). However, many clinical centers adopt data recording systems to evaluate the quality of care and to study diseases and outcomes. The Universitary Hospital Meyer Institute Research Hospital (IRCCS) is a national referral center for managing these pediatric cases of non-infectious chronic uveitis, estimated to constitute 95% of all pediatric uveitis cases
Conditions
- Uveitis
Sponsors & Collaborators
-
Meyer Children's Hospital IRCCS
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-10
- Primary Completion
- 2032-02-01
- Completion
- 2032-05-02
Countries
- United States
- Belgium
- Greece
- Italy
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis
NCT03209219 ·Status: COMPLETED ·Phase: PHASE3
-
Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs
NCT02819206 ·Status: COMPLETED ·Phase: NA
-
Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children
NCT01861561 ·Status: TERMINATED ·Phase: PHASE4
-
Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
NCT01717170 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
NCT00116090 ·Status: COMPLETED
-
Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis
NCT00404482 ·Status: COMPLETED
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis
NCT00918554 ·Status: TERMINATED ·Phase: PHASE4
-
Immun Response in Children With MIS-C
NCT05052424 ·Status: UNKNOWN
-
Lyon Sarcoid Uveitis Cohort
NCT03863782 ·Status: RECRUITING
-
Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
NCT00001541 ·Status: COMPLETED
-
38 Week Extension Study to CAIN457C2303
NCT01093846 ·Status: TERMINATED ·Phase: PHASE3
-
The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
NCT00646425 ·Status: TERMINATED ·Phase: PHASE2
-
MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN
NCT05495893 ·Status: UNKNOWN ·Phase: PHASE4
-
Retrospective Comparison of the Efficacy of Methotrexate and Azathioprine as Background Treatment for Uveitis of Undetermined Origin: Single-centre Retrospective Study From 2005 to 2020
NCT05370690 ·Status: UNKNOWN
-
Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
NCT03371095 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
NCT05767047 ·Status: RECRUITING ·Phase: PHASE3
-
Phase III Study in Refractory Behcet's Disease
NCT00995709 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis
NCT07298928 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT05017142 ·Status: RECRUITING
-
Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis
NCT05101447 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
NCT00685373 ·Status: COMPLETED ·Phase: PHASE3
-
Hematopoietic Stem Cell Support in Vasculitis
NCT00278512 ·Status: TERMINATED ·Phase: PHASE1
-
Alemtuzumab for ANCA Associated Refractory Vasculitis
NCT01405807 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Eye Tissue for Sarcoidosis
NCT00001278 ·Status: COMPLETED